A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

January 31, 2013

Study Completion Date

April 30, 2013

Conditions
Brainstem Glioma
Interventions
DRUG

Capecitabine

Capecitabine was supplied as film-coated tablets.

RADIATION

Radiation therapy

Local irradiation using conformal, volume-based delivery techniques. The nominal energy of the X-rays was ≥ 4 MV.

Trial Locations (8)

15261

Pittsburgh

19104

Philadelphia

20010

Washington D.C.

27710

Durham

38015

Memphis

60614

Chicago

77030

Houston

94143-0780

San Francisco

All Listed Sponsors
collaborator

Pediatric Brain Tumor Consortium

NETWORK

lead

Hoffmann-La Roche

INDUSTRY

NCT01118377 - A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas | Biotech Hunter | Biotech Hunter